Requesting the Auditor to assess the social and financial effects of mandated health insurance coverage for intravenous ketamine therapy to treat.

The bill requests the Auditor to evaluate both the social and financial impacts of a proposed mandate requiring health insurance coverage for a portion of the costs of intravenous ketamine therapy for treating depression. This assessment is mandated by Hawaii Revised Statutes, section 23-51, which requires such evaluations before any legislative measure mandating health insurance coverage for specific health services can be considered. The Auditor must submit a report to the Legislature no later than twenty days before the convening of the Regular Session of 2026.

Requesting the Auditor to assess the social and financial effects of mandated health insurance coverage for intravenous ketamine therapy to treat.

The bill requests the Auditor to evaluate both the social and financial impacts of a proposed mandate requiring health insurance coverage for a portion of the costs of intravenous ketamine therapy for treating depression. This assessment is mandated by Hawaii Revised Statutes, section 23-51, which requires such evaluations before any legislative measure mandating health insurance coverage for specific health services can be considered. The Auditor must submit a report to the Legislature no later than twenty days before the convening of the Regular Session of 2026.